{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:03:16Z","timestamp":1781650996842,"version":"3.54.5"},"reference-count":97,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T00:00:00Z","timestamp":1420761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cephalalgia"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Headaches recur in up to 87% of migraine patients visiting the emergency department (ED), making ED recidivism a management challenge. We aimed herein to determine the role of corticosteroids in the acute management of migraine in the ED and outpatient care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Advanced search strategies employing PubMed\/MEDLINE, Web of Science, and Cochrane Library databases inclusive of a relevant gray literature search was employed for Clinical Studies and Systematic Reviews by combining the terms \u201cmigraine\u201d and \u201ccorticosteroids\u201d spanning all previous years since the production of synthetic corticosteroids ca. 1950 until August 30, 2014. Methods were in accordance with MOOSE guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-five studies (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u20093989, median age 37.5 years, interquartile range or IQR 35\u201341 years; median male:female ratio 1:4.23, IQR 1:2.1\u20136.14; 52% ED-based, 56% randomized-controlled) and four systematic reviews were included. International Classification of Headache Disorders criteria were applied in 64%. Nineteen studies (76%) indicated observed outcome differences favoring benefits of corticosteroids, while six (24%) studies indicated non-inferior outcomes for corticosteroids. Median absolute risk reduction was 30% (range 6%\u201348.2%), and 11% (6%\u201348.6%) for 24-, and 72-hour headache recurrence, respectively. Parenteral dexamethasone was the most commonly (56%) administered steroid, at a median single dose of 10\u2009mg (range 4\u201324\u2009mg). All meta-analyses revealed efficacy of adjuvant corticosteroids to various abortive medications\u2014indicating generalizability. Adverse effects were tolerable. Higher disability, status migrainosus, incomplete pain relief, and previous history of headache recurrence predicted outcome favorability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our literature review suggests that with corticosteroid treatment, recurrent headaches become milder than pretreated headaches and later respond to nonsteroidal therapy. Single-dose intravenous dexamethasone is a reasonable option for managing resistant, severe, or prolonged migraine attacks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0333102414566200","type":"journal-article","created":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T00:52:33Z","timestamp":1420851153000},"page":"996-1024","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":66,"title":["The place of corticosteroids in migraine attack management: A 65-year systematic review with pooled analysis and critical appraisal"],"prefix":"10.1177","volume":"35","author":[{"given":"YW","family":"Woldeamanuel","sequence":"first","affiliation":[{"name":"Stanford Headache and Facial Pain Program, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"Rapoport","sequence":"additional","affiliation":[{"name":"Department of Neurology, The David Geffen School of Medicine at UCLA in Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RP","family":"Cowan","sequence":"additional","affiliation":[{"name":"Stanford Headache and Facial Pain Program, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,1,9]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61729-2"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.041007646.x"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480010072027"},{"key":"e_1_3_3_5_2","first-page":"1","article-title":"National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary","volume":"26","author":"Niska R","year":"2010","unstructured":"Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report 2010; 26: 1\u201331.","journal-title":"Natl Health Stat Report"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39566.806725.BE"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.041007638.x"},{"key":"e_1_3_3_8_2","unstructured":"Focus on migraine management: Appropriate use of triptans. Drug Therapy Council Newsletter 2002."},{"key":"e_1_3_3_9_2","first-page":"S62","article-title":"The cost of migraine and its treatment","volume":"11","author":"Goldberg LD","year":"2005","unstructured":"Goldberg LD. The cost of migraine and its treatment. Am J Manag Care 2005; 11 (2 Suppl): S62\u2013S67.","journal-title":"Am J Manag Care"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(95)70259-8"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00840.x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000150904.28131.DD"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(98)70126-X"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2001.tb01147.x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(05)82928-2"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.1998.tb02819.x"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2008.01092.x"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.02176.x"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2008.09.005"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1988.hed2810675.x"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.0420s1003.x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(92)90097-P"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100000147"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.64.10_suppl_2.S9"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01500.x"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70090-0"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100720300043"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1992.1203133.x"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coms.2007.12.008"},{"key":"e_1_3_3_30_2","first-page":"173","volume-title":"New advances in headache research","author":"Hardebo J","year":"1991","unstructured":"Hardebo J, Suzuki N Evidence for neurogenic inflammation upon activation of trigeminal fibers in the internal carotid artery and dural vessels, but not to pial arteries and their cortical branches. In: Rose FC (ed). New advances in headache research, London: Smith-Gordon, 1991, pp. 173\u2013176."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.07-12-04129.1987"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-011-0408-3"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/033310240102100705"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(86)90244-7"},{"key":"e_1_3_3_35_2","first-page":"S16","article-title":"Neurogenic inflammation in the pathophysiology and treatment of migraine","volume":"43","author":"Moskowitz MA","year":"1993","unstructured":"Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43 (6 Suppl 3): S16\u2013S20.","journal-title":"Neurology"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00496.x"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1185\/0300799039117001"},{"key":"e_1_3_3_38_2","first-page":"380","article-title":"A double-blind study of ganaxolone in the acute treatment of migraine headaches with or without an aura in premenopausal females","volume":"38","author":"Data J","year":"1998","unstructured":"Data J, Britch K, Westergaard N, . A double-blind study of ganaxolone in the acute treatment of migraine headaches with or without an aura in premenopausal females. Headache 1998; 38: 380\u2013380.","journal-title":"Headache"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413520084"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00232-3"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826170ce"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.09.017"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1995.1505384.x"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-009-0110-x"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102412469737"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a6cb72"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480090092034"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(69)90096-1"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/220911a0"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(94)90014-0"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1515\/REVNEURO.2002.13.1.59"},{"key":"e_1_3_3_52_2","volume-title":"Steroid drugs","author":"Applezweig N","year":"1962","unstructured":"Applezweig N. Steroid drugs, New York: McGraw-Hill, 1962."},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109433"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0552-08.2008"},{"key":"e_1_3_3_55_2","unstructured":"World Health Organization. WHO\u2019s pain ladder www.who.int\/cancer\/palliative\/painladder\/en\/ (2010 accessed 18 March 2014)."},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(94)90200-3"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2009.06.004"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2012.05.2554"},{"key":"e_1_3_3_59_2","first-page":"882","article-title":"Cortisone in migraine and histamine headaches","volume":"50","author":"Frohner RN","year":"1953","unstructured":"Frohner RN. Cortisone in migraine and histamine headaches. Rocky Mt Med J 1953; 50: 882\u2013882.","journal-title":"Rocky Mt Med J"},{"key":"e_1_3_3_60_2","first-page":"209","article-title":"Cortisone in allergic migraine","volume":"35","author":"Blumenthal JS","year":"1952","unstructured":"Blumenthal JS. Cortisone in allergic migraine. Minn Med 1952; 35: 209\u2013212.","journal-title":"Minn Med"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1986.hed2602074.x"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1994.hed3406366.x"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01667.x"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38446.498542.8F"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2010.02.007"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.15.1987"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"e_1_3_3_69_2","first-page":"150","article-title":"Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder","volume":"38","author":"Foroughipour M","year":"2013","unstructured":"Foroughipour M, Ghandehari K, Khazaei M, . Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder. Iran J Med Sci 2013; 38 (2 Suppl): 150\u2013155.","journal-title":"Iran J Med Sci"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-12-114"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2004000300025"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2001000500010"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2007.052068"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1481803500014184"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00959.x"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.3923\/ijp.2005.357.359"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.3923\/pjbs.2011.682.687"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2009.08.022"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2007.03.029"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102412462638"},{"key":"e_1_3_3_81_2","first-page":"575","article-title":"Pulse IV steroid and IV valproate combination therapy for sustained relief of chronic, treatment refractory headaches in patients with psychiatric disorders","volume":"74","author":"Askari H","year":"2010","unstructured":"Askari H, Zaidi M. Pulse IV steroid and IV valproate combination therapy for sustained relief of chronic, treatment refractory headaches in patients with psychiatric disorders. Neurology 2010; 74: 575\u2013575.","journal-title":"Neurology"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02654.x"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1481803500006989"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000263652.46222.e8"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000281105.78936.1d"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00648.x"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2000.00028.x"},{"key":"e_1_3_3_88_2","first-page":"855","article-title":"Management of status migrainosus with dexamethasone\u2014A prospective comparison versus methylergonovine and symptomatic care. Program abstracts. 48th Annual Scientific Meeting. American Headache Society. June 22\u201325, 2006, Los Angeles, CA","volume":"46","author":"Kaniecki RG","year":"2006","unstructured":"Kaniecki RG. Management of status migrainosus with dexamethasone\u2014A prospective comparison versus methylergonovine and symptomatic care. Program abstracts. 48th Annual Scientific Meeting. American Headache Society. June 22\u201325, 2006, Los Angeles, CA. Headache 2006; 46: 855\u2013855.","journal-title":"Headache"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1967.hed0702077.x"},{"key":"e_1_3_3_90_2","first-page":"165","article-title":"Towards evidence-based emergency medicine: Best BETs from the Manchester Royal Infirmary","volume":"30","author":"Neill A","year":"2013","unstructured":"Neill A, Brannigan D. Towards evidence-based emergency medicine: Best BETs from the Manchester Royal Infirmary. BET 2: Dexamethasone for reduction of migraine recurrence. Emerg Med J 2013; 30: 165\u2013166.","journal-title":"BET 2: Dexamethasone for reduction of migraine recurrence. Emerg Med J"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12155"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2008.00283.x"},{"key":"e_1_3_3_93_2","unstructured":"Schellenberg ES Dryden D Pasichnyk D et\u00a0al. Acute migraine treatment in emergency settings: Comparative Effectiveness Reviews No. 84. Rockville MD: Agency for Healthcare Research and Quality 2012."},{"key":"e_1_3_3_94_2","first-page":"1459","volume-title":"Goodman and Gilman\u2019s The Pharmacological basis of therapeutics","author":"Schimmer B","year":"1996","unstructured":"Schimmer B, Parker K Adrenocorticotrophic hormone; adrenocortical steroids and their synthetic analogs: Inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman J, Limbird L, Molinoff P, (eds). Goodman and Gilman\u2019s The Pharmacological basis of therapeutics, 9th edn. Toronto: McGraw-Hill, 1996, pp. 1459\u20131485.","edition":"9"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197816030-00006"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-002-0050-0"},{"key":"e_1_3_3_97_2","unstructured":"World Health Organization. Atlas of headache disorders and resources in the world 2011. A collaborative project of World Health Organization and Lifting the Burden 2011."},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.04.019"}],"container-title":["Cephalalgia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0333102414566200","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0333102414566200","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0333102414566200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:46:42Z","timestamp":1777387602000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0333102414566200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,9]]},"references-count":97,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1177\/0333102414566200"],"URL":"https:\/\/doi.org\/10.1177\/0333102414566200","relation":{},"ISSN":["0333-1024","1468-2982"],"issn-type":[{"value":"0333-1024","type":"print"},{"value":"1468-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,9]]}}}